82 related articles for article (PubMed ID: 23315387)
1. Heterogeneous expression of CT10, CT45 and GAGE7 antigens and their prognostic significance in human breast carcinoma.
Zhou X; Yang F; Zhang T; Zhuang R; Sun Y; Fang L; Zhang C; Ma Y; Huang G; Ma F; Song C; Jin B
Jpn J Clin Oncol; 2013 Mar; 43(3):243-50. PubMed ID: 23315387
[TBL] [Abstract][Full Text] [Related]
2. Expression and possible prognostic role of MAGE-A4, NY-ESO-1, and HER-2 antigens in women with relapsing invasive ductal breast cancer: retrospective immunohistochemical study.
Bandić D; Juretić A; Sarcević B; Separović V; Kujundzić-Tiljak M; Hudolin T; Spagnoli GC; Cović D; Samija M
Croat Med J; 2006 Feb; 47(1):32-41. PubMed ID: 16489695
[TBL] [Abstract][Full Text] [Related]
3. Cytoplasmic HuR expression is a prognostic factor in invasive ductal breast carcinoma.
Heinonen M; Bono P; Narko K; Chang SH; Lundin J; Joensuu H; Furneaux H; Hla T; Haglund C; Ristimäki A
Cancer Res; 2005 Mar; 65(6):2157-61. PubMed ID: 15781626
[TBL] [Abstract][Full Text] [Related]
4. Significantly upregulated TACSTD2 and Cyclin D1 correlate with poor prognosis of invasive ductal breast cancer.
Lin H; Huang JF; Qiu JR; Zhang HL; Tang XJ; Li H; Wang CJ; Wang ZC; Feng ZQ; Zhu J
Exp Mol Pathol; 2013 Feb; 94(1):73-8. PubMed ID: 23031786
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of proliferating cell nuclear antigen (PCNA) in infiltrating ductal carcinoma breast.
Aziz SA; Pervez S; Khan SM; Kayani N; Nasir MI
J Coll Physicians Surg Pak; 2005 Apr; 15(4):225-9. PubMed ID: 15857596
[TBL] [Abstract][Full Text] [Related]
6. HAb18G (CD147), a cancer-associated biomarker and its role in cancer detection.
Li Y; Xu J; Chen L; Zhong WD; Zhang Z; Mi L; Zhang Y; Liao CG; Bian HJ; Jiang JL; Yang XM; Li XY; Fan CM; Zhu P; Fu L; Chen ZN
Histopathology; 2009 May; 54(6):677-87. PubMed ID: 19438743
[TBL] [Abstract][Full Text] [Related]
7. Expression of survivin and its clinicopathological correlations in invasive ductal carcinoma of the breast.
Al-Joudi FS; Iskandar ZA; Hasnan J; Rusli J; Kamal Y; Imran AK; Ahmed M; Zakaria J
Singapore Med J; 2007 Jul; 48(7):607-14. PubMed ID: 17609820
[TBL] [Abstract][Full Text] [Related]
8. Inhibin/activin subunits (inhibin-alpha, -betaA and -betaB) are differentially expressed in human breast cancer and their metastasis.
Mylonas I; Jeschke U; Shabani N; Kuhn C; Friese K; Gerber B
Oncol Rep; 2005 Jan; 13(1):81-8. PubMed ID: 15583806
[TBL] [Abstract][Full Text] [Related]
9. COX-2 expression in human breast carcinomas: correlation with clinicopathological features and prognostic molecular markers.
Miglietta A; Toselli M; Ravarino N; Vencia W; Chiecchio A; Bozzo F; Motta M; Torchio B; Bocca C
Expert Opin Ther Targets; 2010 Jul; 14(7):655-64. PubMed ID: 20536410
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathologic correlation of cancer stem cell markers CD44, CD24, VEGF and HIF-1α in ductal carcinoma in situ and invasive ductal carcinoma of breast: an immunohistochemistry-based pilot study.
Wang Z; Shi Q; Wang Z; Gu Y; Shen Y; Sun M; Deng M; Zhang H; Fang J; Zhang S; Xie F
Pathol Res Pract; 2011 Aug; 207(8):505-13. PubMed ID: 21802218
[TBL] [Abstract][Full Text] [Related]
11. [Expression of the genes FHIT, Bcl-2 and Bax in breast infiltrating ductal carcinoma and clinicopathological significance thereof].
Wang ZB; Zhao P; Liu M; Li XH
Zhonghua Yi Xue Za Zhi; 2006 Aug; 86(31):2171-6. PubMed ID: 17064501
[TBL] [Abstract][Full Text] [Related]
12. [Relationship of oncogene C-erbB2 expression to ER, PR and PS2 in breast cancer and its prognostic significance].
Yang JQ; Chen L; Xing TY
Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 May; 35(3):334-6, 357. PubMed ID: 15181828
[TBL] [Abstract][Full Text] [Related]
13. Expression of metallothionein in invasive ductal breast cancer in relation to prognosis.
Zhang R; Zhang H; Wei H; Luo X
J Environ Pathol Toxicol Oncol; 2000; 19(1-2):95-7. PubMed ID: 10905514
[TBL] [Abstract][Full Text] [Related]
14. [Expression and prognostic value of transcriptional factor sp1 in breast cancer].
Wang XB; Peng WQ; Yi ZJ; Zhu SL; Gan QH
Ai Zheng; 2007 Sep; 26(9):996-1000. PubMed ID: 17927860
[TBL] [Abstract][Full Text] [Related]
15. Reduced nuclear expression of transcription factor AP-2 associates with aggressive breast cancer.
Pellikainen J; Kataja V; Ropponen K; Kellokoski J; Pietiläinen T; Böhm J; Eskelinen M; Kosma VM
Clin Cancer Res; 2002 Nov; 8(11):3487-95. PubMed ID: 12429639
[TBL] [Abstract][Full Text] [Related]
16. Learning to predict relapse in invasive ductal carcinomas based on the subcellular localization of junctional proteins.
Asgarian N; Hu X; Aktary Z; Chapman KA; Lam L; Chibbar R; Mackey J; Greiner R; Pasdar M
Breast Cancer Res Treat; 2010 Jun; 121(2):527-38. PubMed ID: 19787450
[TBL] [Abstract][Full Text] [Related]
17. Increased expression of fibroblastic growth factor receptor 2 is correlated with poor prognosis in patients with breast cancer.
Sun S; Jiang Y; Zhang G; Song H; Zhang X; Zhang Y; Liang X; Sun Q; Pang D
J Surg Oncol; 2012 Jun; 105(8):773-9. PubMed ID: 22006548
[TBL] [Abstract][Full Text] [Related]
18. FOXA1 expression in breast cancer--correlation with luminal subtype A and survival.
Badve S; Turbin D; Thorat MA; Morimiya A; Nielsen TO; Perou CM; Dunn S; Huntsman DG; Nakshatri H
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4415-21. PubMed ID: 17671124
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical expression of T, Tn and sialyl-Tn antigens and clinical outcome in human breast carcinoma.
Imai J; Ghazizadeh M; Naito Z; Asano G
Anticancer Res; 2001; 21(2B):1327-34. PubMed ID: 11396208
[TBL] [Abstract][Full Text] [Related]
20. Cancer/testis antigen CT45: analysis of mRNA and protein expression in human cancer.
Chen YT; Hsu M; Lee P; Shin SJ; Mhawech-Fauceglia P; Odunsi K; Altorki NK; Song CJ; Jin BQ; Simpson AJ; Old LJ
Int J Cancer; 2009 Jun; 124(12):2893-8. PubMed ID: 19296537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
